Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katerina Chavatza
Observed names:
Aikaterina Chavatza,
K Chavatza,
K. Chavatza
Institutions:
National and Kapodistrian University of Athens,
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens,
University General Hospital Attikon
Observed institutions:
National and Kapodistrian University of Athens,
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens,
University General Hospital Attikon
ORCID:
0000-0002-1274-0909
Observed ORCID:
0000-0002-1274-0909
OpenAlex ID:
A5007559247
Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort
2020
·
D Nikolopoulos
, M Kostopoulou
, et al.
·
Lupus
·
64
Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
2020
·
Dionysis S Nikolopoulos
, Myrto Kostopoulou
, et al.
·
Lupus Science & Medicine
·
32
PDF
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
2021
·
Katerina Chavatza
, Myrto Kostopoulou
, et al.
·
Annals of the Rheumatic Diseases
·
23
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study
2024
·
Chrysoula G Gialouri
, Aglaia Chalkia
, et al.
·
Rheumatology
·
20
Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study
2020
·
Maria Karampeli
, Konstantinos Thomas
, et al.
·
Mediterranean Journal of Rheumatology
·
20
PDF
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation
2024
·
Spyridon Katechis
, Dionysis Nikolopoulos
, et al.
·
Rheumatology
·
15
PDF
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus
2025
·
Dionysis Nikolopoulos
, George Sentis
, et al.
·
Annals of the Rheumatic Diseases
·
11
Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus
2025
·
Panagiotis Garantziotis
, Georgia Savina Moysidou
, et al.
·
RMD Open
·
6
PDF
Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies
2022
·
Ourania Gioti
, Katerina Chavatza
, et al.
·
Lupus
·
6
Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes
2025
·
Katerina Chavatza
, Elisavet Mastrostamati
, et al.
·
RMD Open
·
3
Temporal trends in lupus pregnancy over four decades in a referral centre: pregnancy planning and hydroxychloroquine use are associated with improved outcomes
2025
·
Dionysia Mandilara
, Spyridon Katechis
, et al.
·
Rheumatology Advances in Practice
·
2
PDF
Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves
2024
·
Konstantinos Protopapas
, Konstantinos Thomas
, et al.
·
Biomedicines
·
2
Pos0759 the Journey of Patients From First Symptoms to Diagnosis of Systemic Lupus Erythematosus (sle): an Observational Study
2021
·
N. Kapsala
, S. Flouda
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
ABS0416 PERSISTENT-RELAPSING SARS-CoV-2 INFECTION FOLLOWING RITUXIMAB TREATMENT FOR AUTOIMMUNE RHEUMATIC DISEASES: NATURAL HISTORY AND IMPLICATIONS FOR MANAGEMENT
2025
·
K. Chavatza
, M.E. Antonogiannaki
, et al.
·
Annals of the Rheumatic Diseases
·
1
Pos0757 Systemic Lupus Erythematosus (sle) Diagnosed During Hospitalization: Clinical Phenotype and Performance of the Sle Risk Probability Index (slerpi)
2021
·
N. Kapsala
, D. Nikolopoulos
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Whole-blood transcriptomics identifies a distinct metabolic and inflammatory signature in lupus arthritis compared with rheumatoid arthritis
2026
·
George Sentis
, Chrysoula Kalantzi
, et al.
·
Journal of Autoimmunity
Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes
2026
·
Εda Otman Akat
, Myrto Kostopoulou
, et al.
·
Annals of the Rheumatic Diseases
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study
2026
·
Katerina Chavatza
, Chrysoula G Gialouri
, et al.
·
RMD Open
PDF
Pos1097 Rates of Relapses and Serious Adverse Events in Patients With Gpa or Mpa Receiving Rituximab for Maintenance Therapy: a Multicentre, Retrospective Study
2024
·
C.G. Gialouri
, A. Chalkia
, et al.
·
Annals of the Rheumatic Diseases
P88 Baseline factors associated with subsequent development of incident nephritis in patients with systemic lupus erythematosus: a retrospective cohort study
2024
·
Spyridon Katechis
, Dionysis Nikolopoulos
, et al.
·
Lupus Science & Medicine
PDF
Ab0625 the Attribution of Neuropsychiatric Events in Systemic Lupus Erythematosus: Data From “attikon” Lupus Cohort
2023
·
D. Nikolopoulos
, N. Kapsala
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0365 Relapses Are Common Ιν Severe Hematological Sle: Real-life Experience From the “attikon” Lupus Cohort
2022
·
G.S. Moysidou
, S. Flouda
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0210 a Predominant Non-specific Interstitial Pneumonia Pattern and Aberrant Transcriptomic Neutrophil-mediated Immunity Characterize a Contemporary Ra-ild Cohort
2022
·
S. Flouda
, A. Grivas
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0786 Unmet Treatment Needs in Systemic Lupus Erythematosus (sle): a Cross-sectional Assessment of Disease Activity in Sle Patients During Their Last Visit
2021
·
O. Gioti
, K. Chavatza
, et al.
·
Annals of the Rheumatic Diseases
Pos0764 Eular Recommendation-based Quality Indicators (qis) for Systemic Lupus Erythematosus (sle): Elaboration, Final Set, Performance and Initial Validation
2021
·
K. Chavatza
, M. Kostopoulou
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
25
Citation count:
208
H-index:
7
I10-index:
7
Year
Topic
Type